CN111138430A - Method for synthesizing imidazole-containing fused heterocyclic compound - Google Patents

Method for synthesizing imidazole-containing fused heterocyclic compound Download PDF

Info

Publication number
CN111138430A
CN111138430A CN202010083616.5A CN202010083616A CN111138430A CN 111138430 A CN111138430 A CN 111138430A CN 202010083616 A CN202010083616 A CN 202010083616A CN 111138430 A CN111138430 A CN 111138430A
Authority
CN
China
Prior art keywords
formyl
pentamethylcyclopentadienyl
iii
rhodium
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010083616.5A
Other languages
Chinese (zh)
Inventor
沈娜娜
李彬
范学森
张新迎
杨玉洁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Normal University
Original Assignee
Henan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Normal University filed Critical Henan Normal University
Priority to CN202010083616.5A priority Critical patent/CN111138430A/en
Publication of CN111138430A publication Critical patent/CN111138430A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Abstract

The invention discloses a method for synthesizing imidazole-containing fused heterocyclic compounds, which comprises the steps of synthesizing 3-formyl-2-aryl imidazo [1,2-a]Pyridine or 3-formyl-2-heteroaryl imidazo [1,2-a]Pyridine compounds, 5-formyl-6-arylimidazo [2,1-b]Thiazole or 5-formyl-6-heteroarylimidazo [2,1-b]Thiazole compound or 3-formyl-2-arylbenzo [2 ], [ solution of a salt of a carboxylic acidd]Imidazo [2,1-b]Thiazole or 3-formyl-2-heteroarylbenzo [2 ]d]Imidazo [2,1-b]The thiazole compound and the cyclic α -diazo-1, 3-diketone compound are subjected to a series reaction to synthesize a target product, namely the imidazole fused heterocyclic compound.

Description

Method for synthesizing imidazole-containing fused heterocyclic compound
Technical Field
The invention belongs to the technical field of organic synthesis, and particularly relates to a synthesis method of imidazole-containing fused heterocyclic compounds.
Background
Imidazole is an important nitrogen-containing heterocyclic compound and has biological activities of resisting cancer, malaria, tumor, bacteria, virus and the like. Furthermore, imidazoles are also the main building blocks of many natural products and organic functional molecules. The imidazopyridine compound is a special imidazole-containing fused heterocyclic compound and has wide application in the fields of pharmaceutical chemistry, material science and the like. In the field of medicinal chemistry, there are currently a number of marketed drugs containing an imidazopyridine skeleton, such as: zolpidem (Zolpidem), Olprinone (Olprinone), thalipidem (Saripideem), necopiden (Necopidem), and the like. In addition, the compounds also have biological activities of diminishing inflammation, resisting bacteria, resisting viruses, resisting tumors and the like; in the field of material science, imidazopyridine compounds are widely applied to biological probes, fluorescent dyes, photoelectric materials and the like. In view of the importance of the compounds, researchers develop various methods for synthesizing imidazole-containing fused heterocyclic compounds, but the developed methods have the defects of difficult obtainment of raw materials, multiple reaction steps, harsh reaction conditions, high environmental factors and the like, so that the application of the developed methods in actual production is limited to a certain extent. Therefore, research and development of a novel method for synthesizing the imidazole-containing fused heterocyclic compound from cheap and easily available raw materials under mild reaction conditions through simple operation steps have important theoretical significance and important application value.
Disclosure of Invention
The technical problem solved by the invention is to provide a synthesis method of imidazole-fused heterocyclic compounds, the synthesis method synthesizes target products of imidazole-fused heterocyclic compounds through the series reaction between 3-formyl-2-aryl imidazo [1,2-a ] pyridine or 3-formyl-2-heteroaryl imidazo [1,2-a ] pyridine compounds, 5-formyl-6-aryl imidazo [2,1-b ] thiazole or 5-formyl-6-heteroaryl imidazo [2,1-b ] thiazole compounds or 3-formyl-2-aryl benzo [ d ] imidazo [2,1-b ] thiazole compounds or 3-formyl-2-heteroaryl benzo [ d ] imidazo [2,1-b ] thiazole compounds and cyclic α -diazo-1, 3-diketone compounds, and the method has the advantages of simple operation, mild conditions, wide substrate application range and the like, and is suitable for industrial production.
The invention adopts the following technical scheme for solving the technical problems, and the synthesis method of the imidazole-containing fused heterocyclic compound is characterized in that the specific synthesis process comprises the steps of dissolving 3-formyl-2-aryl imidazo [1,2-a ] pyridine or 3-formyl-2-heteroaryl imidazo [1,2-a ] pyridine compound 1 and cyclic α -diazo-1, 3-diketone compound 2 in a solvent, adding a catalyst and an additive, and reacting at 80-140 ℃ to obtain the target product imidazole-containing fused heterocyclic compound 3, wherein the reaction equation in the synthesis method is as follows:
Figure BDA0002381217930000021
wherein R is1Is hydrogen, fluorine, chlorine, bromine, trifluoromethyl, methyl or methoxy, R2Is 2-thienyl, 1-naphthyl, phenyl or substituted phenyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, methyl, methoxy, trifluoromethyl or phenyl, R3Is 1, 2-phenyl, 1, 8-naphthyl, C2-6Alkyl, monosubstituted C2-6Alkyl or disubstituted C2-6Alkyl radical, the monosubstituted C2-6Alkyl or disubstituted C2-6The substituent in the alkyl group being C1-6The catalyst is dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer, bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III), bis (pentamethylcyclopentadienyl) rhodium (III) diacetate (pentamethylcyclopentadienyl) rhodium (III) or dichloro (pentamethylcyclopentadienyl) iridium (III) dimer, and the additive is zinc acetate, silver hexafluoroantimonate, sodium acetate, potassium acetate, cesium acetate, copper acetate, acetic acid, trimethylacetic acid, 2,4, 6-trimethylbenzoic acid, 1-adamantanic acid or trifluoroacetic acid.
More preferably, the ratio of the amount of the 3-formyl-2-arylimidazo [1,2-a ] pyridine or 3-formyl-2-heteroarylimidazo [1,2-a ] pyridine compound 1 to the amount of the cyclic α -diazo-1, 3-dione compound 2 to the amount of the catalyst and the additive is 1:1-2:0.05: 0-3.
More preferably, the ratio of the amount of the 3-formyl-2-arylimidazo [1,2-a ] pyridine or 3-formyl-2-heteroarylimidazo [1,2-a ] pyridine compound 1 to the amount of the cyclic α -diazo-1, 3-dione compound 2 to the amount of the catalyst and the additive is 1:1-2:0.05: 0.1-3.
A synthetic method of imidazole-containing fused heterocyclic compounds is characterized in that the specific synthetic process comprises the steps of dissolving 5-formyl-6-aryl imidazo [2,1-b ] thiazole or 5-formyl-6-heteroaryl imidazo [2,1-b ] thiazole compounds 1 and cyclic α -diazo-1, 3-diketone compounds 2 in a solvent, adding a catalyst and an additive, and reacting at 80-140 ℃ to obtain target products, namely imidazole-containing fused heterocyclic compounds 3, wherein the reaction equation in the synthetic method is as follows:
Figure BDA0002381217930000022
wherein R is1Is 2-thienyl, 1-naphthyl, phenyl or substituted phenyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, methyl, methoxy, trifluoromethyl or phenyl, R2Is 1, 2-phenyl, 1, 8-naphthyl, C2-6Alkyl, monosubstituted C2-6Alkyl or disubstituted C2-6Alkyl radical, the monosubstituted C2-6Alkyl or disubstituted C2-6The substituent in the alkyl group being C1-6The catalyst is dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer, bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III), bis (pentamethylcyclopentadienyl) rhodium (III) diacetate (pentamethylcyclopentadienyl) rhodium (III) or dichloro (pentamethylcyclopentadienyl) iridium (III) dimer, and the additive is zinc acetate, silver hexafluoroantimonate, sodium acetate, potassium acetate, cesium acetate, copper acetate, acetic acid, trimethylacetic acid, 2,4, 6-trimethylbenzoic acid, 1-adamantanic acid or trifluoroacetic acid.
Further preferably, the ratio of the amount of the 5-formyl-6-arylimidazo [2,1-b ] thiazole or 5-formyl-6-heteroarylimidazo [2,1-b ] thiazole compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0-3.
Further preferably, the ratio of the amount of the 5-formyl-6-arylimidazo [2,1-b ] thiazole or 5-formyl-6-heteroarylimidazo [2,1-b ] thiazole compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0.1-3.
A synthetic method of imidazole-containing fused heterocyclic compounds is characterized in that the specific synthetic process comprises the steps of dissolving 3-formyl-2-aryl benzo [ d ] imidazo [2,1-b ] thiazole or 3-formyl-2-heteroaryl benzo [ d ] imidazo [2,1-b ] thiazole compounds 1 and cyclic α -diazo-1, 3-diketone compounds 2 in a solvent, adding a catalyst and an additive, and reacting at 80-140 ℃ to obtain target products, namely imidazole-containing fused heterocyclic compounds 3, wherein the reaction equation in the synthetic method is as follows:
Figure BDA0002381217930000031
wherein R is1Is 2-thienyl, 1-naphthyl, phenyl or substituted phenyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, methyl, methoxy, trifluoromethyl or phenyl, R2Is 1, 2-phenyl, 1, 8-naphthyl, C2-6Alkyl, monosubstituted C2-6Alkyl or disubstituted C2-6Alkyl radical, the monosubstituted C2-6Alkyl or disubstituted C2-6The substituent in the alkyl group being C1-6The catalyst is dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer, bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III), bis (pentamethylcyclopentadienyl) rhodium (III) diacetate (pentamethylcyclopentadienyl) rhodium (III) or dichloro (pentamethylcyclopentadienyl) iridium (III) dimer, and the additive is zinc acetate, silver hexafluoroantimonate, sodium acetate, potassium acetate, cesium acetate, copper acetate, acetic acid, trimethylacetic acid, 2,4, 6-trimethylbenzoic acid, 1-adamantanic acid or trifluoroacetic acid.
Further preferably, the ratio of the amount of the 3-formyl-2-arylbenzo [ d ] imidazo [2,1-b ] thiazole or 3-formyl-2-heteroarylbenzo [ d ] imidazo [2,1-b ] thiazole compound 1 to the amount of the cyclic α -diazo-1, 3-dione compound 2 to the amount of the catalyst and the additive is 1:1-2:0.05: 0-3.
Further preferably, the ratio of the amount of the 3-formyl-2-arylbenzo [ d ] imidazo [2,1-b ] thiazole or 3-formyl-2-heteroarylbenzo [ d ] imidazo [2,1-b ] thiazole compound 1 to the amount of the cyclic α -diazo-1, 3-dione compound 2 to the amount of the catalyst and the additive is 1:1-2:0.05: 0.1-3.
Compared with the prior art, the invention has the following advantages: (1) the raw materials are cheap and easy to obtain or easy to prepare; (2) the synthesis process is a one-pot series reaction, is simple and efficient, and avoids resource waste and environmental pollution; (3) the reaction condition is mild, and the operation is simple and convenient; (4) the atom economy of the reaction is high; (5) the application range of the substrate is wide. Therefore, the invention provides a simple, high-efficiency, economical and practical novel method for synthesizing imidazole-containing fused heterocyclic compounds.
Detailed Description
The present invention is described in further detail below with reference to examples, but it should not be construed that the scope of the above subject matter of the present invention is limited to the following examples, and that all the technologies realized based on the above subject matter of the present invention belong to the scope of the present invention.
Example 1
Figure BDA0002381217930000041
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and zinc acetate (37mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (5mg, 8%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.89(t,J=6.8Hz,2H),3.47(t,J=6.8Hz,2H),3.76(s,3H),6.96(t,J=6.8Hz,1H),7.46-7.50(m,1H),7.62-7.66(m,1H),7.68-7.71(m,1H),7.82(d,J=9.2Hz,1H),8.40(s,1H),8.50(d,J=6.8Hz,1H),8.80-8.84(m,2H).13C NMR(100MHz,CDCl3)δ:28.7,36.3,52.0,112.1,113.5,118.1,122.4,123.1,124.7,126.88,126.93,127.6,129.0,129.20,129.25,144.2,149.2,173.7,200.6.HRMS calcd forC20H17N2O3:333.1239[M+H]+,found:333.1228。
example 2
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and acetic acid (12mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in an oil bath at 120 ℃ for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (34mg, 51%) as a white solid.
Example 3
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and potassium acetate (20mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (22mg, 33%) as a white solid.
Example 4
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and sodium acetate (16mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (19mg, 28%) as a white solid.
Example 5
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and cesium acetate (38mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (15mg, 22%) as a white solid.
Example 6
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and copper acetate (40mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (7mg, 10%) as a white solid.
Example 7
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and silver hexafluoroantimonate (7mg,0.02mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (28mg, 42%) as a white solid.
Example 8
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and trimethylacetic acid (20mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (31mg, 46%) as a white solid.
Example 9
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and trifluoroacetic acid (23mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (25mg, 37%) as a white solid.
Example 10
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in an oil bath at 120 ℃ for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (41mg, 62%) as a white solid.
Example 11
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer (6mg,0.01mmol), and 1-adamantanecarboxylic acid (36mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (29mg, 44%) as a white solid.
Example 12
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (52mg, 78%) as a white solid.
Example 13
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), pentamethylcyclopentadienyl rhodium (III) diacetate (7mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 120 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (33mg, 50%) as a white solid.
Example 14
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), dichloro (pentamethylcyclopentadienyl) iridium (III) dimer (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in an oil bath at 120 ℃ for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give the product 3aa (37mg, 55%) as a white solid.
Example 15
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give the product 3aa (56mg, 84%) as a white solid.
Example 16
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in an 80 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (44mg, 67%) as a white solid.
Example 17
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and the pressure tube was sealed and placed in an oil bath at 140 ℃ for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (47mg, 71%) as a white solid.
Example 18
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL) and bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath for reaction for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to yield the product 3aa (21mg, 32%) as a white solid.
Example 19
Figure BDA0002381217930000081
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2b (41mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol.: petroleum ether/ethyl acetate: 2/1) to give the product 3ab (57mg, 82%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,DMSO-d6)δ:1.99-2.06(m,2H),2.49-2.52(m,2H),3.32(t,J=7.2Hz,2H),3.63(s,3H),7.24(t,J=6.8Hz,1H),7.68-7.76(m,3H),7.91(d,J=8.8Hz,1H),8.75(d,J=7.6Hz,1H),8.88(d,J=8.4Hz,1H),9.17(s,1H),9.36(d,J=6.8Hz,1H).13C NMR(100MHz,DMSO-d6)δ:20.4,33.2,51.8,112.6,116.8,117.7,123.2,123.3,126.8,127.0,127.3,127.6,127.7,128.2,129.3,130.6,143.7,149.3,173.7,202.7.HRMS calcd for C21H19N2O3:347.1396[M+H]+,found:347.1371。
example 20
Figure BDA0002381217930000082
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2c (46mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, thenThen the pressure pipe is sealed and placed in an oil bath at 100 ℃ for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, dried by spinning, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3ac (59mg, 82%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:1.78-1.84(m,2H),1.86-1.93(m,2H),2.42(t,J=7.2Hz,2H),3.17(t,J=7.2Hz,2H),3.67(s,3H),7.01(td,J1=6.8Hz,J2=1.2Hz,1H),7.51(ddd,J1=9.2Hz,J2=6.4Hz,J3=1.2Hz,1H),7.65-7.74(m,2H),7.86(d,J=9.2Hz,1H),8.35(s,1H),8.59(d,J=6.8Hz,1H),8.80(d,J=7.6Hz,1H),8.85(dd,J1=8.0Hz,J2=1.2Hz,1H).13C NMR(100MHz,CDCl3)δ:24.6,24.7,33.9,41.5,51.6,112.1,113.1,118.2,122.6,123.2,124.8,126.95,126.99,127.03,127.6,129.1,129.3,129.9,144.1,149.2,174.0,202.8.HRMS calcd for C22H21N2O3:361.1552[M+H]+,found:361.1552。
example 21
Figure BDA0002381217930000091
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2d (50mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give the product 3ad (64mg, 85%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:1.24(s,6H),2.58(s,2H),3.33(s,2H),3.60(s,3H),6.99(td,J1=6.8Hz,J2=0.8Hz,1H),7.49(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.2Hz,1H),7.65-7.74(m,2H),7.85(d,J=9.2Hz,1H),8.44(s,1H),8.61(d,J=6.4Hz,1H),8.70-8.72(m,1H),8.86(dd,J1=8.0Hz,J2=1.2Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,33.7,44.7,50.9,51.2,112.0,113.1,118.1,122.5,123.3,124.8,126.8,126.9,127.1,127.4,129.0,129.1,131.6,143.8,149.1,172.9,203.2.HRMS calcd forC23H23N2O3:375.1709[M+H]+,found:375.1709。
example 22
Figure BDA0002381217930000092
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2e (46mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried and separated on a silica gel column (vol.: petroleum ether/ethyl acetate 2/1) to give the product 3ae as a white solid (62mg, 86%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:1.11(d,J=6.8Hz,3H),2.39-2.51(m,2H),2.74-2.86(m,2H),3.42-3.46(m,1H),3.72(s,3H),6.99(t,J=6.8Hz,1H),7.49(t,J=8.0Hz,1H),7.65-7.72(m,2H),8.84(d,J=9.2Hz,1H),8.59(s,1H),8.64(d,J=6.4Hz,1H),8.82-8.84(m,1H),8.92(d,J=8.0Hz,1H).13C NMR(100MHz,CDCl3)δ:20.1,28.1,40.9,48.3,51.6,112.2,114.5,117.9,122.6,123.2,125.0,126.9,127.0,127.7,128.9,129.3,129.5,144.0,149.2,173.4,202.0.HRMS calcd for C22H21N2O3:361.1552[M+H]+,found:361.1549。
example 23
Figure BDA0002381217930000101
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2f (64mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. To be reversedAfter this reaction had ended, it was cooled to room temperature, filtered off with suction, spin-dried and isolated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3af (67mg, 79%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.77(dd,J1=15.6Hz,J2=6.8Hz,1H),2.90(dd,J1=15.6Hz,J2=7.6Hz,1H),3.37(dd,J1=16.0Hz,J2=8.0Hz,1H),3.60-3.65(m,4H),3.92-4.00(m,1H),6.96(t,J=6.8Hz,1H),7.16-7.28(m,5H),7.44-7.48(m,1H),7.55-7.59(m,1H),7.66(t,J=7.2Hz,1H),7.80(d,J=9.2Hz,1H),8.26(s,1H),8.48(d,J=6.8Hz,1H),8.60(d,J=8.4Hz,1H),8.79(d,J=8.0Hz,1H).13C NMR(100MHz,CDCl3)δ:38.9,40.5,48.0,51.7,112.1,113.7,118.0,122.5,123.1,124.9,126.88,126.94,127.0,127.5,128.7,129.2,129.3,129.4,143.0,144.1,149.2,172.6,201.1.HRMScalcd for C27H23N2O3:423.1709[M+H]+,found:423.1709。
example 24
Figure BDA0002381217930000102
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2g (73mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3ag (70mg, 77%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.74(dd,J1=16.0Hz,J2=6.8Hz,1H),2.87(dd,J1=15.6Hz,J2=7.6Hz,1H),3.34(dd,J1=15.6Hz,J2=8.4Hz,1H),3.60-3.66(m,4H),3.72(s,3H),3.87-3.95(m,1H),6.79(d,J=8.8Hz,2H),7.00(td,J1=6.8Hz,J2=1.2Hz,1H),7.14(d,J=8.4Hz,2H),7.50(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.6Hz,1H),7.57-7.62(m,1H),7.68(td,J1=7.6Hz,J2=0.8Hz,1H),7.84(d,J=9.2Hz,1H),8.28(s,1H),8.54(d,J=6.8Hz,1H),8.60(d,J=8.0Hz,1H),8.82(dd,J1=8.0Hz,J2=0.8Hz,1H).13C NMR(100MHz,CDCl3)δ:38.3,40.7,48.4,51.7,55.2,112.1,113.7,114.1,118.1,122.6,123.1,124.9,126.91,126.94,127.5,128.5,129.2,129.3,129.6,134.9,144.0,149.2,158.5,172.7,201.5.HRMS calcd for C28H25N2O4:453.1814[M+H]+,found:453.1813。
example 25
Figure BDA0002381217930000111
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2h (68mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol/vol: petroleum ether/ethyl acetate 2/1) to give the product 3ah (66mg, 76%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.27(s,3H),2.76(dd,J1=16.0Hz,J2=7.2Hz,1H),2.89(dd,J1=15.6Hz,J2=8.0Hz,1H),3.38(dd,J1=15.6Hz,J2=8.0Hz,1H),3.61-3.66(m,4H),3.90-3.97(m,1H),7.02(t,J=6.8Hz,1H),7.07(d,J=8.0Hz,2H),7.13(d,J=7.6Hz,2H),7.50-7.54(m,1H),7.59-7.63(m,1H),7.69(t,J=7.6Hz,1H),7.87(d,J=8.8Hz,1H),8.31(s,1H),8.56(d,J=6.8Hz,1H),8.63(d,J=8.4Hz,1H),8.83(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3)δ:21.0,38.6,40.5,48.3,51.7,112.1,113.7,118.2,122.6,123.1,124.8,126.94,126.96,126.99,127.3,127.5,129.2,129.35,129.41,129.6,136.6,140.0,144.1,149.3,172.7,201.4.HRMS calcd for C28H25N2O3:437.1865[M+H]+,found:437.1862。
example 26
Figure BDA0002381217930000112
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2i (70mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate: 2/1) to give the product 3ai as a white solid (69mg, 78%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.73(dd,J1=16.0Hz,J2=7.2Hz,1H),2.87(dd,J1=16.0Hz,J2=8.0Hz,1H),3.34(dd,J1=16.0Hz,J2=8.8Hz,1H),3.64-3.69(m,4H),3.92-3.99(m,1H),6.92-6.98(m,2H),7.00(td,J1=6.8Hz,J2=1.2Hz,1H),7.18-7.23(m,2H),7.50(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.2Hz,1H),7.57-7.66(m,1H),7.66-7.70(m,1H),7.84(d,J=9.2Hz,1H),8.35(s,1H),8.56(d,J=6.8Hz,1H),8.59(d,J=8.4Hz,1H),8.82(dd,J1=8.4Hz,J2=0.8Hz,1H).13C NMR(100MHz,CDCl3)δ:38.1,40.6,48.0,51.8,112.1,113.7,115.5(d,2JC-F=21.3Hz),118.1,122.5,123.1,124.8,126.86,126.94,127.6,129.0(d,3JC-F=8.1Hz),129.2,129.3,138.6(d,4JC-F=3.3Hz),144.2,149.3,161.7(d,1JC-F=243.9Hz),172.5,200.9.19F NMR(376MHz,CDCl3)δ:-115.8.HRMS calcd for C27H22FN2O3:441.1614[M+H]+,found:441.1610。
example 27
Figure BDA0002381217930000121
Sequentially adding into a 15mL pressure resistant tube1a (44mg,0.2mmol), 2j (75mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol), the pressure tube was then sealed and placed in a 100 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give the product 3aj (72mg, 79%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.73(dd,J1=16.0Hz,J2=7.2Hz,1H),2.87(dd,J1=15.6Hz,J2=7.6Hz,1H),3.34(dd,J1=16.0Hz,J2=8.8Hz,1H),3.62-3.67(m,4H),3.91-3.98(m,1H),7.01(td,J1=6.8Hz,J2=1.2Hz,1H),7.16-7.19(m,2H),7.22-7.25(m,2H),7.50(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.2Hz,1H),7.58-7.62(m,1H),7.69(td,J1=7.6Hz,J2=1.2Hz,1H),7.84(d,J=9.2Hz,1H),8.32(s,1H),8.55(d,J=6.8Hz,1H),8.60(d,J=8.4Hz,1H),8.82(dd,J1=8.0Hz,J2=0.8Hz,1H).13C NMR(100MHz,CDCl3)δ:38.2,40.4,47.8,51.8,112.2,113.7,118.1,122.5,123.2,124.8,126.8,126.9,127.0,127.6,128.8,128.9,129.22,129.25,129.33,132.7,141.5,144.2,149.3,172.4,200.8.HRMS calcd for C27H22ClN2O3:457.1319[M+H]+,found:457.1319。
example 28
Figure BDA0002381217930000122
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2k (88mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol.: petroleum ether/ethyl acetate: 2/1) to give the product 3ak (73mg, 73%) as a white solid. Characterization number of the CompoundThe following is provided:1H NMR(400MHz,CDCl3)δ:2.73(dd,J1=16.0Hz,J2=7.2Hz,1H),2.87(dd,J1=16.0Hz,J2=7.6Hz,1H),3.34(dd,J1=16.0Hz,J2=8.4Hz,1H),3.60-3.66(m,4H),3.89-3.96(m,1H),6.98-7.02(m,1H),7.12(d,J=8.4Hz,2H),7.38(d,J=8.4Hz,2H),7.50(ddd,J1=9.2Hz,J2=6.8Hz,J3=0.8Hz,1H),7.58-7.62(m,1H),7.66-7.70(m,1H),7.83(d,J=9.2Hz,1H),8.29(s,1H),8.54(d,J=7.2Hz,1H),8.60(d,J=8.8Hz,1H),8.80-8.82(m,1H).13C NMR(100MHz,CDCl3)δ:38.3,40.3,47.8,51.8,112.2,113.7,118.1,120.8,122.5,123.2,124.8,126.8,126.9,127.0,127.6,129.18,129.24,129.30,129.33,131.8,142.0,144.1,149.3,172.3,200.7.HRMS calcd for C27H22BrN2O3:501.0814[M+H]+,found:501.0797。
example 29
Figure BDA0002381217930000131
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2l (85mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, dried by spinning, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate: 2/1) to give the product 3al (79mg, 81%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.76(dd,J1=16.0Hz,J2=7.2Hz,1H),2.91(dd,J1=16.0Hz,J2=7.6Hz,1H),3.39(dd,J1=16.0Hz,J2=8.4Hz,1H),3.66-3.71(m,4H),4.00-4.07(m,1H),6.99(t,J=6.8Hz,1H),7.37(d,J=8.0Hz,2H),7.48-7.54(m,3H),7.59(t,J=8.0Hz,1H),7.68(t,J=7.6Hz,1H),7.83(d,J=9.2Hz,1H),8.32(s,1H),8.52(d,J=6.8Hz,1H),8.59(d,J=8.8Hz,1H),8.81(d,J=8.4Hz,1H).13C NMR(150MHz,CDCl3)δ:38.5,40.2,47.5,51.9,112.2,113.7,118.1,122.5,123.2,124.1(q,1JC-F=270.45Hz),124.8,125.7(q,3JC-F=8.4Hz),126.8,126.9,127.0,127.6,128.0,129.0,129.2,129.3(q,2JC-F=32.55Hz),129.4,144.2,147.2,149.4,172.2,200.4.19F NMR(376MHz,CDCl3)δ:-62.5.HRMS calcd for C28H22F3N2O3:491.1583[M+H]+,found:491.1597。
example 30
Figure BDA0002381217930000141
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2m (79mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3am as a white solid (72mg, 76%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.96(dd,J1=15.6Hz,J2=6.8Hz,1H),3.05(dd,J1=16.0Hz,J2=8.0Hz,1H),3.54-3.60(m,4H),3.77(dd,J1=16.0Hz,J2=7.2Hz,1H),4.84-4.90(m,1H),6.91(t,J=6.8Hz,1H),7.35(t,J=8.0Hz,1H),7.41-7.47(m,4H),7.55(t,J=7.6Hz,1H),7.63-7.68(m,2H),7.79-8.81(m,2H),8.13(s,1H),8.17(d,J=8.8Hz,1H),8.26(d,J=6.4Hz,1H),8.64(d,J=8.4Hz,1H),8.78(d,J=8.0Hz,1H).13C NMR(150MHz,CDCl3)δ:40.0,47.4,51.8,112.0,113.7,118.0,122.4,123.0,123.1,124.8,125.4,125.7,126.4,126.8,126.9,127.47,127.53,129.0,129.2,129.3,129.4,131.2,134.1,139.2,144.0,149.2,172.7,201.2.HRMS calcd for C31H25N2O3:473.1865[M+H]+,found:473.1856。
example 31
Figure BDA0002381217930000142
To a 15mL pressure resistant tube were added 1a (44mg,0.2mmol), 2n (66mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give the product 3an (61mg, 71%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.84(dd,J1=15.6Hz,J2=6.8Hz,1H),2.93(dd,J1=16.0Hz,J2=7.6Hz,1H),3.46(dd,J1=16.0Hz,J2=7.6Hz,1H),3.64-3.69(m,4H),4.28-4.35(m,1H),6.87-6.89(m,2H),6.98(t,J=6.8Hz,1H),7.14(t,J=2.8Hz,1H),7.48(t,J=8.0Hz,1H),7.61(t,J=7.6Hz,1H),7.68(t,J=7.6Hz,1H),7.82(d,J=9.2Hz,1H),8.34(s,1H),8.53(d,J=6.4Hz,1H),8.71(d,J=8.4Hz,1H),8.80(d,J=8.0Hz,1H).13C NMR(150MHz,CDCl3)δ:34.2,41.3,48.6,51.9,112.1,113.9,118.0,122.5,123.1,123.7,124.6,124.9,126.88,126.92,127.0,127.6,129.1,129.30,129.33,144.1,146.5,149.3,172.3,200.4.HRMS calcd for C25H21N2O3S:429.1273[M+H]+,found:429.1281。
example 32
Figure BDA0002381217930000151
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2o (52mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol.: petroleum ether/ethyl acetate 2/1) to give the product 3ao as a white solid (68mg, 89%). Characterization of the CompoundThe data are as follows:1H NMR(400MHz,CDCl3)δ:3.39(s,3H),6.86(t,J=6.8Hz,1H),7.40-7.44(m,1H),7.59-7.67(m,3H),7.74-7.81(m,3H),7.91(s,1H),7.99(d,J=7.2Hz,1H),8.30(d,J=6.8Hz,1H),8.86-8.88(m,1H),917-9.20(m,1H).13C NMR(100MHz,CDCl3)δ:52.5,112.0,117.0,118.0,122.3,123.1,125.0,126.9,127.1,127.4,127.9,128.6,129.1,129.4,130.0,130.16,130.21,130.5,132.0,142.9,144.7,149.5,167.1,197.4.HRMS calcd for C24H17N2O3:381.1239[M+H]+,found:381.1224。
example 33
Figure BDA0002381217930000152
To a 15mL pressure tube were added 1a (44mg,0.2mmol), 2p (67mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol/vol: petroleum ether/ethyl acetate 2/1) to give the product 3ap as a white solid (53mg, 62%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:3.49(s,3H),6.96-6.70(m,1H),7.46(d,J=7.60Hz,1H),7.53(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.2Hz,1H),7.62-7.68(m,3H),7.75-7.79(m,1H),7.92(d,J=9.2Hz,1H),8.03(dd,J1=7.2Hz,J2=1.2Hz,1H),8.06(dd,J1=8.0Hz,J2=1.2Hz,1H),8.11(dd,J1=8.0Hz,J2=1.2Hz,1H),8.52(d,J=6.8Hz,1H),8.57(s,1H),8.86(d,J=8.4Hz,1H),8.95-8.97(m,1H).13C NMR(150MHz,CDCl3)δ:52.1,112.0,117.1,118.2,123.0,123.3,124.9,125.1,125.7,126.9,127.0,127.4,128.1,129.3,129.5,130.27,130.34,130.5,131.5,132.5,134.8,139.2,144.6,149.4,169.5,197.8.HRMS calcd for C28H19N2O3:431.1396[M+H]+,found:431.1393。
example 34
Figure BDA0002381217930000161
To a 15mL pressure tube were added 1b (60mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3ba (66mg, 81%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.88(t,J=6.8Hz,2H),3.46(t,J=6.8Hz,2H),3.75(s,3H),6.86-6.90(m,1H),7.36-7.42(m,2H),7.47-7.51(m,2H),7.73-7.78(m,3H),7.92(dd,J1=8.8Hz,J2=2.0Hz,1H),8.37(s,1H),8.41(d,J=6.8Hz,1H),8.80(d,J=8.4Hz,1H),9.09(d,J=2.0Hz,1H).13C NMR(100MHz,CDCl3)δ:28.7,36.1,52.0,112.0,114.2,117.9,122.4,123.6,124.8,125.1,125.7,126.1,127.5,127.6,128.6,128.9,129.3,129.6,140.1,141.1,144.0,149.3,173.7,200.4.HRMS calcd forC26H21N2O3:409.1552[M+H]+,found:409.1550。
example 35
Figure BDA0002381217930000162
To a 15mL pressure tube were added 1c (50mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol.: petroleum ether/ethyl acetate: 2/1) to give the product 3ca (64mg, 88%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.89(t,J=6.8Hz,2H),3.49(t,J=6.8Hz,2H),3.76(s,3H),3.96(s,3H),6.96(t,J=6.8Hz,1H),7.33(dd,J1=8.8Hz,J2=2.4Hz,1H),7.48(t,J=7.6Hz,1H),7.79(d,J=9.2Hz,1H),8.44(s,1H),8.47-8.49(m,2H),8.69(d,J=8.8Hz,1H).13C NMR(100MHz,CDCl3)δ:28.7,35.9,51.9,55.4,106.8,111.9,114.6,117.8,118.3,121.4,121.6,124.5,124.8,126.9,129.4,131.1,144.7,149.5,159.5,173.7,200.2.HRMS calcd for C21H19N2O4:363.1345[M+H]+,found:363.1345。
example 36
Figure BDA0002381217930000171
To a 15mL pressure tube were added 1d (47mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, dried by spinning, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3da (57mg, 82%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.55(s,3H),2.88(t,J=6.8Hz,2H),3.45(t,J=6.4Hz,2H),3.76(s,3H),6.91-6.94(m,1H),7.42-7.47(m,1H),7.50(dd,J1=8.0Hz,J2=1.2Hz,1H),7.77(d,J=9.2Hz,1H),8.33(s,1H),8.44(d,J=7.2Hz,1H),8.60(s,1H),8.66(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3)δ:22.3,28.7,36.2,52.0,111.9,113.6,117.9,122.0,122.9,124.7,124.8,126.2,128.4,128.8,129.1,129.4,137.5,144.1,149.2,173.7,200.7.HRMS calcd for C21H19N2O3:347.1396[M+H]+,found:347.1388。
example 37
Figure BDA0002381217930000172
Sequentially adding into a 15mL pressure resistant tube1e (48mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol), the pressure tube was then sealed and placed in a 100 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give product 3ea as a white solid (54mg, 77%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.90(t,J=6.4Hz,2H),3.49(t,J=6.4Hz,2H),3.77(s,3H),7.00-7.04(m,1H),7.39-7.44(m,1H),7.51-7.55(m,1H),7.80(d,J=9.2Hz,1H),8.50-8.53(m,2H),8.66(dd,J1=12.4Hz,J2=2.8Hz,1H),8.75(dd,J1=9.2Hz,J2=6.4Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,35.7,52.0,111.8(d,2JC-F=24.9Hz),112.2,115.2,116.3(d,2JC-F=24.6Hz),118.0,122.1,123.5,124.9,125.2(d,3JC-F=9.5Hz),127.1(d,4JC-F=4Hz),129.7,130.6(d,3JC-F=10.5Hz),144.5,149.6,162.3(d,1JC-F=242.8Hz),173.7,199.7.19F NMR(376MHz,CDCl3)δ:-111.5.HRMS calcd forC20H16FN2O3:351.1145[M+H]+,found:351.1136。
example 38
Figure BDA0002381217930000181
To a 15mL pressure tube were added 1f (51mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, the reaction mixture was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate: 2/1) to give the product 3fa as a white solid (58mg, 79%). The characterization data for this compound are as follows:1H NMR(400MHz,DMSO-d6)δ:2.81(t,J=6.4Hz,2H),3.58(t,J=6.4Hz,2H),3.68(s,3H),7.22(t,J=6.8Hz,1H),7.68-7.73(m,2H),7.87(d,J=9.2Hz,1H),8.64(d,J=8.8Hz,1H),8.99(s,1H),9.27(s,1H),9.33(d,J=6.4Hz,1H).13C NMR(150MHz,DMSO-d6)δ:28.8,35.8,51.9,112.8,117.6,118.9,123.5,125.0,125.1,125.5,126.2,127.1,127.8,130.0,131.2,132.8,143.8,149.7,173.6,200.6.HRMScalcd for C20H16ClN2O3:367.0849[M+H]+,found:367.0834。
example 39
Figure BDA0002381217930000182
To a 15mL pressure resistant tube were added 1g (60mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, dried by spinning, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate: 2/1) to give product 3ga (63mg, 77%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.90(t,J=6.4Hz,2H),3.47(t,J=6.4Hz,2H),3.79(s,3H),7.03(td,J1=6.8Hz,J2=0.8Hz,1H),7.53(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.2Hz,1H),7.67(dd,J1=8.4Hz,J2=1.6Hz,1H),7.76(d,J=9.2Hz,1H),8.40(s,1H),8.46(d,J=6.8Hz,1H),8.55(d,J=8.8Hz,1H),9.02(d,J=2.0Hz,1H).13CNMR(100MHz,CDCl3)δ:28.6,35.8,52.0,112.4,114.9,118.0,122.4,124.5,124.9,125.1,126.9,129.2,129.8,130.0,130.1,144.0,149.5,173.7,199.8.HRMS calcd forC20H16BrN2O3:411.0344[M+H]+,found:411.0323。
example 40
Figure BDA0002381217930000191
To a 15mL pressure tube were added 1h (58mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath for reaction for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol: petroleum ether/ethyl acetate 2/1) to give the product 3ha (59mg, 74%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.93(t,J=6.4Hz,2H),3.51(t,J=6.4Hz,2H),3.78(s,3H),7.03(td,J1=6.8Hz,J2=0.8Hz,1H),7.51-7.55(m,1H),7.78-7.83(m,2H),8.50(d,J=6.8Hz,1H),8.53(s,1H),8.83(d,J=8.8Hz,1H),9.21(s,1H).13C NMR(100MHz,CDCl3)δ:28.6,35.9,52.0,112.6,115.1,118.2,122.6(q,3JC-F=2.3Hz),123.3,123.9,124.5(q,1JC-F=270.5Hz),124.8(q,3JC-F=4.6Hz),124.9,128.2,128.26,128.30,129.2(q,2JC-F=31.7Hz),129.9,143.7,149.6,173.7,199.9.19F NMR(376MHz,CDCl3)δ:-61.8.HRMS calcd for C21H16F3N2O3:401.1113[M+H]+,found:401.1106。
EXAMPLE 41
Figure BDA0002381217930000192
To a 15mL pressure tube were added 1i (47mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol. ratio: petroleum ether/ethyl acetate: 2/1) to give the product 3ia (58mg, 84%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.60(s,3H),2.87(t,J=6.8Hz,2H),3.45(t,J=6.8Hz,2H),3.75(s,3H),6.92-6.95(m,1H),7.43-7.47(m,2H),7.79(d,J=9.2Hz,1H),8.31(s,1H),8.46(d,J=6.4Hz,1H),8.58(s,1H),8.73(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3)δ:21.6,28.7,36.1,51.9,111.9,112.7,118.0,122.48,122.53,124.7,126.8,126.9,127.2,128.8,129.0,129.6,137.0,143.8,149.1,173.7,200.5.HRMS calcd for C21H19N2O3:347.1396[M+H]+,found:347.1387。
example 42
Figure BDA0002381217930000201
To a 15mL pressure tube were added 1j (48mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give product 3ja (53mg, 76%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.90(t,J=6.4Hz,2H),3.48(t,J=6.4Hz,2H),3.76(s,3H),7.02(td,J1=6.8Hz,J2=0.8Hz,1H),7.41(dd,J1=11.4Hz,J2=8.0Hz,1H),7.51(ddd,J1=9.2Hz,J2=6.8Hz,J3=1.2Hz,1H),7.56(td,J1=8.0Hz,J2=5.6Hz,1H),7.93(d,J=9.2Hz,1H),8.48(s,1H),8.57(d,J=6.8Hz,1H),8.59(d,J=9.6Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,36.5,52.0,112.48,112.55(d,2JC-F=19.7Hz),114.2,116.8(d,2JC-F=12.8Hz),118.7,122.6(d,4JC-F=4Hz),123.3,124.4,127.4(d,3JC-F=8.4Hz),128.9(d,4JC-F=2Hz),129.3,131.3(d,3JC-F=4.1Hz),141.4(d,4JC-F=4Hz),149.3(d,3JC-F=4.1Hz),159.5(d,1JC-F=254.2Hz),173.6,200.7.19F NMR(376MHz,CDCl3)δ:-113.1.HRMS calcd for C20H16FN2O3:351.1145[M+H]+,found:351.1138。
example 43
Figure BDA0002381217930000202
To a 15mL pressure tube were added 1k (51mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 h. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol: petroleum ether/ethyl acetate: 2/1) to give the product 3ka as a white solid (59mg, 80%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.90(t,J=6.4Hz,2H),3.44(t,J=6.8Hz,2H),3.78(s,3H),7.37(dd,J1=9.6Hz,J2=1.2Hz,1H),7.58-7.69(m,3H),8.22(s,1H),8.40(s,1H),8.67(d,J=8.0Hz,1H),8.71(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,36.3,52.0,113.1,118.3,120.1,122.2,122.8,123.0,126.7,126.9,127.1,127.7,129.0,129.7,130.3,144.1,147.1,173.7,200.6.HRMS calcd forC20H16ClN2O3:367.0849[M+H]+,found:367.0848。
example 44
Figure BDA0002381217930000211
To a 15mL pressure resistant tube were added 1l (50mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, the reaction mixture was cooled to room temperature, filtered under suction, dried by spinning, and separated by means of a silica gel column (volume ratio: petroleum ether/ethyl acetate: 2/1) to give 3l of a white solid producta (60mg, 83%). The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.88(t,J=6.4Hz,2H),3.46(t,J=6.4Hz,2H),3.75(s,3H),3.93(s,3H),6.61(dd,J1=7.2Hz,J2=2.4Hz,1H),7.00(d,J=2.4Hz,1H),7.59-7.67(m,2H),8.24(d,J=7.6Hz,1H),8.32(s,1H),8.72-8.74(m,1H),8.88(d,J=8.0Hz,1H).13C NMR(100MHz,CDCl3)δ:28.7,36.0,51.9,55.8,94.7,107.3,113.4,122.1,122.9,125.0,126.2,126.5,126.9,127.3,127.4,129.1,144.6,151.4,161.2,173.8,200.2.HRMS calcd for C21H19N2O4:363.1345[M+H]+,found:363.1342。
example 45
Figure BDA0002381217930000212
To a 15mL pressure tube were added 1m (48mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried and separated on a silica gel column (vol.: petroleum ether/ethyl acetate 2/1) to give the product 3ma (58mg, 83%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.89(t,J=6.4Hz,2H),3.44(t,J=6.4Hz,2H),3.76(s,3H),6.84(td,J1=7.2Hz,J2=4.4Hz,1H),7.14(dd,J1=10.4Hz,J2=8.0Hz,1H),7.61(td,J1=8.0Hz,J2=1.6Hz.1H),7.66-7.70(m,1H),8.26(d,J=6.4Hz,1H),8.29(s,1H),8.70(d,J=8.4Hz,1H),8.84(d,J=8.0Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,36.4,52.0,111.0(d,3JC-F=6.9Hz),111.3(d,2JC-F=16.9Hz),113.2,121.1(d,4JC-F=5.3Hz),123.1,123.3,126.7,126.9,127.1,127.7,129.1,130.2,141.6(d,2JC-F=27.4Hz),143.6,151.5(d,1JC-F=252.3Hz),173.6,200.8.19F NMR(376MHz,CDCl3)δ:-127.7.HRMS calcd for C20H16FN2O3:351.1145[M+H]+,found:351.1135。
example 46
Figure BDA0002381217930000221
To a 15mL pressure resistant tube were added 1n (54mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (vol.: petroleum ether/ethyl acetate 2/1) to give the product 3na (61mg, 80%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.87(t,J=6.4Hz,2H),3.42(t,J=6.4Hz,2H),3.78(s,3H),6.81(t,J=6.4Hz,1H),7.23-7.27(m,1H),7.49-7.54(m,2H),7.60(d,J=9.2Hz,1H),7.98-8.00(m,1H),8.05(d,J=7.2Hz,1H),8.20(s,1H),8.25(d,J=6.8Hz,1H),9.15(s,1H),9.37(s,1H).13C NMR(100MHz,CDCl3)δ:28.7,35.7,52.0,112.3,115.4,117.5,120.8,121.5,124.3,124.8,125.8,126.3,126.8,126.9,128.02,128.04,128.5,129.2,131.3,132.4,144.2,148.6,173.8,200.0.HRMS calcd forC24H19N2O3:383.1396[M+H]+,found:383.1385。
example 47
Figure BDA0002381217930000222
To a 15mL pressure tube were added 1o (46mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction is finished, cooling to room temperature, carrying out suction filtration, spin-drying, and separating by a silica gel column (volume ratio: petroleum ether/ethyl acetate)2/1) gave the product 3oa (44mg, 65%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.89(t,J=6.8Hz,2H),3.55(t,J=6.8Hz,2H),3.76(s,3H),7.01(td,J1=6.8Hz,J2=0.8Hz,1H),7.54(ddd,J1=9.2Hz,J2=6.4Hz,J3=1.2Hz,1H),7.67(d,J=5.6Hz,1H),7.80(d,J=9.2Hz,1H),8.49(s,1H),8.51(d,J=5.6Hz,1H),8.56(d,J=7.2Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,34.3,52.0,111.5,112.1,118.2,123.8,125.4,125.5,126.1,127.6,130.4,131.5,136.6,143.1,150.4,173.7,197.6.HRMS calcd for C18H15N2O3S:339.0803[M+H]+,found:339.0801。
example 48
Figure BDA0002381217930000231
To a 15mL pressure tube were added 1p (46mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol) and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, spin-dried, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate 2/1) to give the product 3pa (50mg, 74%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.87(t,J=6.8Hz,2H),3.41(t,J=6.8Hz,2H),3.75(s,3H),6.91(d,J=4.4Hz,1H),7.55-7.59(m,1H),7.62-7.66(m,1H),7.72(d,J=4.8Hz,1H),8.19(s,1H),8.63(dd,J1=8.0Hz,J2=0.8Hz,1H),8.76(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3)δ:28.6,34.3,52.0,112.5,113.7,117.6,122.4,123.5,126.61,126.65,126.8,126.9,128.0,128.6,146.9,157.1,173.7,200.7.HRMScalcd for C18H15N2O3S:339.0803[M+H]+,found:339.0786。
example 49
Figure BDA0002381217930000232
To a 15mL pressure resistant tube were added 1q (56mg,0.2mmol), 2a (37mg,0.3mmol), methanol (1mL), bis (hexafluoroantimonic acid) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III) (8mg,0.01mmol), and 2,4, 6-trimethylbenzoic acid (33mg,0.2mmol) in that order, and then the pressure resistant tube was sealed and placed in a 100 ℃ oil bath to react for 12 hours. After the reaction was complete, it was cooled to room temperature, filtered with suction, dried by spinning, and separated on a silica gel column (volume ratio: petroleum ether/ethyl acetate: 2/1) to give the product 3qa (63mg, 87%) as a white solid. The characterization data for this compound are as follows:1H NMR(400MHz,CDCl3)δ:2.90(t,J=6.4Hz,2H),3.45(t,J=6.4Hz,2H),3.78(s,3H),7.29(t,J=7.6Hz,1H),7.40(t,J=8.0Hz,1H),7.46(t,J=8.0Hz,1H),7.50(t,J=7.6Hz,1H),7.63(d,J=8.0Hz,1H),7.77(d,J=8.0Hz,1H),8.24(s,1H),8.48(d,J=8.4Hz,1H),8.59(d,J=8.4Hz,1H).13C NMR(100MHz,CDCl3)δ:28.7,36.5,52.0,112.7,113.1,122.2,124.30,124.33,124.81,126.2,126.3,126.71,126.76,126.79,127.6,129.2,129.5,132.4,146.5,155.4,173.7,200.9.HRMS calcd forC22H17N2O3S:389.0960[M+H]+,found:389.0954。
the foregoing embodiments have described the general principles, principal features and advantages of the invention. It will be understood by those skilled in the art that the present invention is not limited to the embodiments described above, which are merely illustrative of the principles of the present invention, and that various changes and modifications may be made without departing from the scope of the principles of the present invention, and the invention is intended to be covered by the appended claims.

Claims (9)

1. A synthetic method of imidazole-containing fused heterocyclic compounds is characterized in that the specific synthetic process comprises the steps of dissolving 3-formyl-2-aryl imidazo [1,2-a ] pyridine or 3-formyl-2-heteroaryl imidazo [1,2-a ] pyridine compounds 1 and cyclic α -diazo-1, 3-diketone compounds 2 in a solvent, adding a catalyst and an additive, and reacting at 80-140 ℃ to obtain target products, namely imidazole-containing fused heterocyclic compounds 3, wherein the reaction equation in the synthetic method is as follows:
Figure FDA0002381217920000011
wherein R is1Is hydrogen, fluorine, chlorine, bromine, trifluoromethyl, methyl or methoxy, R2Is 2-thienyl, 1-naphthyl, phenyl or substituted phenyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, methyl, methoxy, trifluoromethyl or phenyl, R3Is 1, 2-phenyl, 1, 8-naphthyl, C2-6Alkyl, monosubstituted C2-6Alkyl or disubstituted C2-6Alkyl radical, the monosubstituted C2-6Alkyl or disubstituted C2-6The substituent in the alkyl group being C1-6The catalyst is dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer, bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III), bis (pentamethylcyclopentadienyl) rhodium (III) diacetate (pentamethylcyclopentadienyl) rhodium (III) or dichloro (pentamethylcyclopentadienyl) iridium (III) dimer, and the additive is zinc acetate, silver hexafluoroantimonate, sodium acetate, potassium acetate, cesium acetate, copper acetate, acetic acid, trimethylacetic acid, 2,4, 6-trimethylbenzoic acid, 1-adamantanic acid or trifluoroacetic acid.
2. The method for synthesizing imidazole-containing fused heterocyclic compounds according to claim 1, wherein the ratio of the amounts of the 3-formyl-2-arylimidazo [1,2-a ] pyridine or 3-formyl-2-heteroarylimidazo [1,2-a ] pyridine compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0-3.
3. The method for synthesizing imidazole-containing fused heterocyclic compounds according to claim 1, wherein the ratio of the amounts of the 3-formyl-2-arylimidazo [1,2-a ] pyridine or 3-formyl-2-heteroarylimidazo [1,2-a ] pyridine compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0.1-3.
4. A synthetic method of imidazole-containing fused heterocyclic compounds is characterized in that the specific synthetic process comprises the steps of dissolving 5-formyl-6-aryl imidazo [2,1-b ] thiazole or 5-formyl-6-heteroaryl imidazo [2,1-b ] thiazole compounds 1 and cyclic α -diazo-1, 3-diketone compounds 2 in a solvent, adding a catalyst and an additive, and reacting at 80-140 ℃ to obtain target products, namely imidazole-containing fused heterocyclic compounds 3, wherein the reaction equation in the synthetic method is as follows:
Figure FDA0002381217920000012
wherein R is1Is 2-thienyl, 1-naphthyl, phenyl or substituted phenyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, methyl, methoxy, trifluoromethyl or phenyl, R2Is 1, 2-phenyl, 1, 8-naphthyl, C2-6Alkyl, monosubstituted C2-6Alkyl or disubstituted C2-6Alkyl radical, the monosubstituted C2-6Alkyl or disubstituted C2-6The substituent in the alkyl group being C1-6The catalyst is dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer, bis (hexafluoroantimonate) triethylenenitrile (pentamethylcyclopentadienyl) rhodium (III), bis (pentamethylcyclopentadienyl) rhodium (III) diacetate (pentamethylcyclopentadienyl) rhodium (III) or dichloro (pentamethylcyclopentadienyl) iridium (III) dimer, and the additive is zinc acetate, silver hexafluoroantimonate, sodium acetate, potassium acetate, cesium acetate, copper acetate, acetic acid, trimethylacetic acid, 2,4, 6-trimethylbenzoic acid, 1-adamantanic acid or trifluoroacetic acid.
5. The method for synthesizing imidazole-containing fused heterocyclic compounds according to claim 4, wherein the ratio of the amounts of the 5-formyl-6-arylimidazo [2,1-b ] thiazole or 5-formyl-6-heteroarylimidazo [2,1-b ] thiazole compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0-3.
6. The method for synthesizing imidazole-containing fused heterocyclic compounds according to claim 4, wherein the ratio of the amounts of the 5-formyl-6-arylimidazo [2,1-b ] thiazole or 5-formyl-6-heteroarylimidazo [2,1-b ] thiazole compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0.1-3.
7. A synthetic method of imidazole-containing fused heterocyclic compounds is characterized in that the specific synthetic process comprises the steps of dissolving 3-formyl-2-aryl benzo [ d ] imidazo [2,1-b ] thiazole or 3-formyl-2-heteroaryl benzo [ d ] imidazo [2,1-b ] thiazole compounds 1 and cyclic α -diazo-1, 3-diketone compounds 2 in a solvent, adding a catalyst and an additive, and reacting at 80-140 ℃ to obtain target products, namely imidazole-containing fused heterocyclic compounds 3, wherein the reaction equation in the synthetic method is as follows:
Figure FDA0002381217920000021
wherein R is1Is 2-thienyl, 1-naphthyl, phenyl or substituted phenyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, methyl, methoxy, trifluoromethyl or phenyl, R2Is 1, 2-phenyl, 1, 8-naphthyl, C2-6Alkyl, monosubstituted C2-6Alkyl or disubstituted C2-6Alkyl radical, the monosubstituted C2-6Alkyl or disubstituted C2-6The substituent in the alkyl group being C1-6Alkyl, phenyl, substituted phenyl, 2-thienyl or 1-naphthyl, the substituent in the substituted phenyl is fluorine, chlorine, bromine, trifluoromethyl, methyl or methoxy, the solvent is methanol, the catalyst is dichloro (pentamethylcyclopentadienyl) rhodium (III) dimer, bis (hexafluoroantimonate) triacetonitrile (pentamethylcyclopentadienyl) rhodium (III), pentamethylcyclopentadienyl rhodium (III) diacetate or dichloro (pentamethylcyclopentadienyl) iridium (III) dimer, and the additive is zinc acetate, silver hexafluoroantimonate, acetateSodium, potassium acetate, cesium acetate, copper acetate, acetic acid, trimethylacetic acid, 2,4, 6-trimethylbenzoic acid, 1-adamantanic acid, or trifluoroacetic acid.
8. The method for synthesizing imidazole-containing fused heterocyclic compounds according to claim 7, wherein the ratio of the amounts of the 3-formyl-2-arylbenzo [ d ] imidazo [2,1-b ] thiazole or 3-formyl-2-heteroarylbenzo [ d ] imidazo [2,1-b ] thiazole compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0-3.
9. The method for synthesizing imidazole-containing fused heterocyclic compounds according to claim 7, wherein the ratio of the amounts of the 3-formyl-2-arylbenzo [ d ] imidazo [2,1-b ] thiazole or 3-formyl-2-heteroarylbenzo [ d ] imidazo [2,1-b ] thiazole compound 1, the cyclic α -diazo-1, 3-dione compound 2, the catalyst and the additive is 1:1-2:0.05: 0.1-3.
CN202010083616.5A 2020-02-10 2020-02-10 Method for synthesizing imidazole-containing fused heterocyclic compound Pending CN111138430A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010083616.5A CN111138430A (en) 2020-02-10 2020-02-10 Method for synthesizing imidazole-containing fused heterocyclic compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010083616.5A CN111138430A (en) 2020-02-10 2020-02-10 Method for synthesizing imidazole-containing fused heterocyclic compound

Publications (1)

Publication Number Publication Date
CN111138430A true CN111138430A (en) 2020-05-12

Family

ID=70527250

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010083616.5A Pending CN111138430A (en) 2020-02-10 2020-02-10 Method for synthesizing imidazole-containing fused heterocyclic compound

Country Status (1)

Country Link
CN (1) CN111138430A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112174962A (en) * 2020-10-27 2021-01-05 河南师范大学 Synthesis method of benzo [ e ] pyridylimidazo [4,5-g ] isoindole-1, 3(2H) -diketone compound
CN112194662A (en) * 2020-10-27 2021-01-08 河南师范大学 Synthetic method of benzo [ a ] pyrrolo [3,4-c ] carbazole-1, 3(2H,8H) -diketone compound
CN113185536A (en) * 2021-04-29 2021-07-30 河南师范大学 Synthesis method of pyrazolidone benzo 1, 3-oxygen-nitrogen hetero-compound
CN113717107A (en) * 2021-09-08 2021-11-30 河南师范大学 Synthesis method of N-acyl benzimidazole compound
CN114315696A (en) * 2021-12-17 2022-04-12 河南师范大学 Synthesis method of 5-acyl aromatic ring carbazole compound

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106588747A (en) * 2016-11-24 2017-04-26 河南师范大学 Synthetic method for aromatic[a]carbazole compounds
CN108484477A (en) * 2018-07-05 2018-09-04 河南师范大学 A kind of synthetic method of 5- acyl groups benzo [a] carbazole compound
CN110372708A (en) * 2019-08-26 2019-10-25 河南师范大学 A kind of synthetic method of 5H- benzo [c] imidazo [1,2-a] azepine -6- carboxylic acid compound
CN110483507A (en) * 2019-08-28 2019-11-22 河南师范大学 A kind of synthetic method of naphtho- [1 ', 2 ': 4,5] imidazo [1,2-a] pyridine compounds and their
CN110511221A (en) * 2019-08-28 2019-11-29 河南师范大学 A kind of synthetic method of polysubstituted aromatic ring simultaneously [1 ', 2 ': 4,5] imidazo [1,2-a] pyridine compounds and their

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106588747A (en) * 2016-11-24 2017-04-26 河南师范大学 Synthetic method for aromatic[a]carbazole compounds
CN108484477A (en) * 2018-07-05 2018-09-04 河南师范大学 A kind of synthetic method of 5- acyl groups benzo [a] carbazole compound
CN110372708A (en) * 2019-08-26 2019-10-25 河南师范大学 A kind of synthetic method of 5H- benzo [c] imidazo [1,2-a] azepine -6- carboxylic acid compound
CN110483507A (en) * 2019-08-28 2019-11-22 河南师范大学 A kind of synthetic method of naphtho- [1 ', 2 ': 4,5] imidazo [1,2-a] pyridine compounds and their
CN110511221A (en) * 2019-08-28 2019-11-29 河南师范大学 A kind of synthetic method of polysubstituted aromatic ring simultaneously [1 ', 2 ': 4,5] imidazo [1,2-a] pyridine compounds and their

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SHENGHAI GUO ET AL.: "Selective Synthesis of Indazolo[2,3-a]quinolines via Rh(III)-Catalyzed Oxidant-Free [4+2] or [5+1] Annulation of 2-Aryl-2H-indazoles with α-Diazo Carbonyl Compounds", 《ADVANCED SYNTHESIS & CATALYSIS 》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112174962A (en) * 2020-10-27 2021-01-05 河南师范大学 Synthesis method of benzo [ e ] pyridylimidazo [4,5-g ] isoindole-1, 3(2H) -diketone compound
CN112194662A (en) * 2020-10-27 2021-01-08 河南师范大学 Synthetic method of benzo [ a ] pyrrolo [3,4-c ] carbazole-1, 3(2H,8H) -diketone compound
CN113185536A (en) * 2021-04-29 2021-07-30 河南师范大学 Synthesis method of pyrazolidone benzo 1, 3-oxygen-nitrogen hetero-compound
CN113717107A (en) * 2021-09-08 2021-11-30 河南师范大学 Synthesis method of N-acyl benzimidazole compound
CN114315696A (en) * 2021-12-17 2022-04-12 河南师范大学 Synthesis method of 5-acyl aromatic ring carbazole compound
CN114315696B (en) * 2021-12-17 2023-12-01 河南师范大学 Synthesis method of 5-acyl aryl cyclocarbazole compound

Similar Documents

Publication Publication Date Title
CN111138430A (en) Method for synthesizing imidazole-containing fused heterocyclic compound
CN109912606B (en) Synthesis method of pyrimido indazole compound
CN108276287B (en) Synthesis method of 4-oxo acrylate derivative catalyzed by visible light
CN108997298B (en) Synthetic method of naphtho [1,8-bc ] pyran compound
CN110511221B (en) Synthesis method of polysubstituted aromatic ring [1',2':4,5] imidazo [1,2-a ] pyridine compound
CN110483507B (en) Synthetic method of aromatic ring [1',2':4,5] imidazo [1,2-a ] pyridine compound
Oh et al. Gold‐Catalyzed Sequential Activation of Propargylic Carboxylates: A Facile Route to Benzoannulenes
CN108610278B (en) Synthetic method of 6-amino-5-acyl benzo [ a ] carbazole compound
CN110183443B (en) Synthesis method of indolo [3,2-c ] quinoline compound
CN108727385B (en) Preparation method of polysubstituted dihydropyrimido indolone derivative
CN108658841A (en) A kind of carbazole compound and preparation method thereof
CN105622625B (en) A kind of synthetic method of benzopyrone and Imidazopyridine compound
CN114315696B (en) Synthesis method of 5-acyl aryl cyclocarbazole compound
Morgan et al. Mechanism of arylation of nucleophiles by aryllead triacetates. Part 1. Exclusion of a pathway involving aryl free radicals
CN115572300A (en) Synthesis method of sulfonamide substituted polycyclic quinazolinone compound
CN113045530B (en) Method for preparing naphthopyran compounds by ruthenium catalysis
CN111004234A (en) C3-site halogenation method of 2-phenylimidazo [1,2- α ] pyridine compound
CN114605361A (en) Method for synthesizing gamma-hydroxy-gamma-perfluoromethylbutenolide compound
CN109485594B (en) Synthetic method of 3-alkynyl pyrrole compound
CN115010635B (en) Synthesis method of (E) -beta-selenenyl sulfone compound
CN105693778A (en) N-methoxyl formamide-orientated method for synthesizing ferrocene and pyridone derivative
CN109369497B (en) Synthesis method of N-pyrrolylpiperidine compound
CN108314649B (en) Synthetic method of 6-phenylphenanthridine compound
CN111704630A (en) 3-arylformyl naphtho-isoxazole or 3-arylformyl anthraceno-isoxazole derivative and synthetic method thereof
CN115385836B (en) Synthesis method of amino selenate compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200512